Why is Amerise BioScie falling/rising?

As of 19-Sep, Amerise Biosciences Ltd is currently priced at 0.70, reflecting a rise of 0.01 or 1.45%. Despite this positive movement today, the stock has underperformed in the longer term, with a year-to-date decline of 42.15% and a 1-year return of -12.50%. Today's performance summary indicates that the stock has outperformed its sector by 1.6%, but it is trading below its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages. Additionally, there has been a decrease in investor participation, with delivery volume falling by 6.58% compared to the 5-day average, suggesting a lack of strong buying interest. There is no information available regarding positive or negative factors that could further explain the stock's recent movement.
In the broader market context, Amerise Biosciences Ltd's short-term performance over the past week shows a decline of 2.78%, while the benchmark Sensex has increased by 0.88%. This indicates that the stock is not only underperforming relative to the market but also struggling significantly compared to the benchmark over the past month and year. The stark contrast in performance highlights the challenges faced by Amerise Biosciences Ltd in attracting investor confidence amidst a generally positive market environment.